Synthesis and structure of new tetracopper(II) complexes bridged by 2-{N'-[2-(dimethylamino)ethyl]oxamido}benzoate: DNA-binding and anticancer activity.
Two new circular tetranuclear copper(II) complexes, [Cu(4)(dmoxba)(2)(bpy)(2)(CH(3)OH)(2)](pic)(2)·2H(2)O (1) and [Cu(4)(dmoxba)(2)(phen)(2)](pic)(2)·2CH(3)OH (2), where dmoxba, pic, bpy and phen stand for the anion of 2-{N'-[2-(dimethylamino)ethyl]oxamido}benzoate, picrate, 2,2'-bipyridine and 1,10-phenanthroline, respectively, have been synthesized and structurally characterized by X-ray single-crystal diffraction. Both the complexes have embedded inversion centers and similar complex cations assembled by the oxamide-bridges and carboxylate-bridges of two cis-dmoxba(3-) ligands. The Cu···Cu separations through the oxamide-bridge and the carboxylato-bridge are 5.1991(4) and 5.4674(4) Å in 1 and 5.1843(5) and 5.2138(5) Å in 2, respectively. Both copper(II) ions are in square-pyramidal environments in 1. While in complex 2, the inner and exo copper(II) ions have square-planar and square-pyramidal coordination geometries, respectively. In both the crystals, three-dimensional supramolecular structures are formed by hydrogen bonds and π-π stacking interactions. The DNA-binding properties and anticancer activities of the two complexes were investigated. The results suggest that the two complexes interact with HS-DNA in the mode of intercalation with the intrinsic binding constants 5.0×10(4) M(-1) (1) and 6.7×10(4) M(-1) (2). The influence of structural variation of the terminal ligands in the tetranuclear complexes on DNA-binding properties is preliminarily discussed.
Marine Drug & Food Institute, Ocean University of China, Qingdao, Shandong 266003, PR China.
Yong-Jun
YJ
Zheng
Xiao-Wen
XW
Li
Yan-Tuan
YT
Li
Zhi-Yong
ZY
Wu
Cui-Wei
CW
Yan
D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000633:toxicity; D017209:Apoptosis / Q000187:drug effects; D001565:Benzoates / Q000737:chemistry*; D045744:Cell Line, Tumor; D056831:Coordination Complexes / Q000138:chemical synthesis / Q000737:chemistry* / Q000633:toxicity; D003300:Copper / Q000737:chemistry*; D018360:Crystallography, X-Ray; D004247:DNA / Q000378:metabolism*; D006801:Humans; D006860:Hydrogen Bonding; D008968:Molecular Conformation; D010618:Phenanthrolines / Q000737:chemistry; D013056:Spectrophotometry, Ultraviolet
D000970:Antineoplastic Agents; D001565:Benzoates; D056831:Coordination Complexes; D010618:Phenanthrolines; D003300:Copper; D004247:DNA; C025205:1,10-phenanthroline